Free Trial

Vanguard Group Inc. Buys 362,127 Shares of Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Key Points

  • Vanguard Group Inc. has increased its stake in Xylem Inc. by 1.3%, acquiring an additional 362,127 shares to total approximately 29 million shares, valued at $3.47 billion.
  • Xylem reported earnings of $1.26 EPS for the last quarter, exceeding analysts' estimates by $0.11, with revenue up 6.1% year-over-year.
  • The company recently announced a quarterly dividend of $0.40 per share, which represents a 1.1% yield and a payout ratio of 41.56%.
  • Looking to Export and Analyze Xylem Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Vanguard Group Inc. increased its position in Xylem Inc. (NYSE:XYL - Free Report) by 1.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,006,544 shares of the industrial products company's stock after acquiring an additional 362,127 shares during the quarter. Vanguard Group Inc. owned about 11.92% of Xylem worth $3,465,122,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Northern Trust Corp grew its position in shares of Xylem by 42.0% during the 4th quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock valued at $379,204,000 after purchasing an additional 966,399 shares in the last quarter. OVERSEA CHINESE BANKING Corp Ltd boosted its stake in Xylem by 390.5% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock valued at $122,009,000 after buying an additional 813,100 shares during the period. Vaughan Nelson Investment Management L.P. bought a new stake in Xylem during the first quarter valued at $89,828,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Xylem during the fourth quarter worth about $83,139,000. Finally, GAMMA Investing LLC increased its stake in Xylem by 15,322.5% in the 1st quarter. GAMMA Investing LLC now owns 506,630 shares of the industrial products company's stock worth $60,522,000 after acquiring an additional 503,345 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Trading Down 0.1%

Shares of XYL opened at $143.42 on Friday. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $145.33. The firm has a market cap of $34.91 billion, a price-to-earnings ratio of 37.25, a PEG ratio of 2.49 and a beta of 1.11. The firm has a 50 day moving average price of $130.90 and a 200-day moving average price of $124.97. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The company had revenue of $2.30 billion for the quarter, compared to analysts' expectations of $2.20 billion. During the same quarter last year, the company earned $1.09 EPS. The firm's revenue was up 6.1% compared to the same quarter last year. As a group, equities research analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 26th. Investors of record on Thursday, May 29th were issued a dividend of $0.40 per share. The ex-dividend date was Thursday, May 29th. This represents a $1.60 annualized dividend and a yield of 1.1%. Xylem's dividend payout ratio is currently 41.56%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on XYL shares. Raymond James Financial raised Xylem to a "hold" rating in a report on Thursday, May 15th. Stifel Nicolaus lifted their target price on shares of Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research report on Friday, August 1st. UBS Group increased their price target on shares of Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a report on Tuesday. Robert W. Baird dropped their price objective on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Finally, Royal Bank Of Canada upped their target price on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $151.57.

Get Our Latest Analysis on XYL

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines